PAXGENE Ribonucleic acid extraction, quality control and aliquoting services​

SOL #: 75N98026Q00583Pre-Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

MD

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Other Professional Services (R499)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 10, 2026
2
Response Deadline
Jun 20, 2026, 1:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has issued a Presolicitation for PAXgene Ribonucleic acid (RNA) extraction, quality control, and aliquoting services. These services are required to support ongoing NIDDK clinical protocol research and downstream transcriptomic analysis. Responses are due by June 20, 2026.

Scope of Work

The objective is to procure services for RNA extraction, quantitation, normalization, Agilent quality control, and aliquoting for samples collected from 50 clinical participants. The contractor shall provide services for 122 PAXgene tube units, including:

  • High-quality RNA extraction from PAXgene tubes using validated protocols.
  • RNA quantitation and normalization for consistent sample concentrations.
  • Deoxyribonuclease (DNase) treatment to remove genomic DNA contaminants.
  • RNA integrity and quality assessments using Agilent instrumentation.
  • Aliquoting up to twenty-one (21) aliquots per sample.
  • Secure frozen storage conditions to prevent sample degradation.
  • Shipment of samples on dry ice.
  • Maintenance of complete documentation and traceability records.

Quality Control & Repository Management

  • All specimens must meet the contractor’s established quality control acceptance criteria upon receipt.
  • The contractor must inspect specimens and immediately notify NIDDK of any compromised or nonconforming samples.
  • Specimen integrity verification includes visual inspection and temperature monitoring.
  • The contractor shall provide certificates of analysis, donor documentation, shipping documentation, and chain-of-custody records.
  • Specimens must be maintained and stored under appropriate frozen conditions.
  • Order status updates and shipment tracking information must be provided to NIDDK personnel.

Contract & Timeline

  • Type: Presolicitation
  • Product/Service Code: R499 (Other Professional Services)
  • Set-Aside: None specified
  • Response Due: June 20, 2026, 1:00 PM EDT
  • Published: June 10, 2026, 2:26 PM EDT
  • Place of Performance: Maryland (20892), United States

Contact Information

People

Points of Contact

John BurtonPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Pre-Solicitation
Posted: Jun 10, 2026
PAXGENE Ribonucleic acid extraction, quality control and aliquoting services​ | GovScope